National Council on Radiation Protection and Measurements (NCRP).Protection of the thyroid gland in the event of release of radioiodine.Washington, DC: NCRP report no. 55, August 1, 1977: 1–60.
2.
Background material for the development of the Food and Drug Administration's recommendations of thyroid-blocking with potassium iodide.Rockville, MD: U.S. Department of Health and Human Services, Food and Drug Administration report, 1981: 1–17.
3.
LengemannFW, ThompsonJC.Prophylactic and therapeutic measures for radioiodine contamination–a review.Health Phys1963; 9: 1391–7.
EarlyPJ, SodeeDB eds. Principles and practice of nuclear medicine.St. Louis, MO: CV Mosby, 1985: 943 (appendix A).
6.
CrockerD.Nuclear reactor accidents — the use of KI as a blocking agent against radioiodine uptake in the thyroid — a review.Health Phys1984; 46: 1265–79.
7.
ConradR.Thyroid nodule and leukemia in a Marshallese population exposed to fallout 20 years ago (abstract).Radiat Res1974; 59: 313.
8.
BeckerD.Physiological basis for the use of potassium iodide as a thyroid blocking agent — logistic issues in its distribution.Bull NY Acad Med1983; 59: 1003–9.
9.
WolffJ.Physiologic aspects of iodide excess in relation to radiation protection.J Mol Med1980; 4: 151–65.
10.
BlumM, EisenbudM.Reduction of thyroid irradiation from 131I by potassium iodide.JAMA1967; 200: 1036–9.
11.
SternthalE, LipwirthL, StanleyB, AbreauC, FangS, BravermanL.Suppression of thyroid radioiodine uptake by various doses of stable iodide.N Engl J Med1980; 303: 1083–8.
12.
RobbinsJ.Indications for using potassium iodide to protect the thyroid from low level internal irradiation.Bull NY Acad Med1983; 59: 1028–38.
13.
BeckerD, BravermanL, DunnJThe use of iodine as a thyroidal blocking agent in the event of a reactor accident.JAMA1984; 252: 659–61.
14.
MillerK, WhiteW, LangC, WeidnerW.Skin exposure to I blocks thyroid uptake of 131I.Health Phys1985; 49: 791–4.
